LICENSE AGREEMENTLicense Agreement • July 7th, 2015 • Gensight Biologics • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 7th, 2015 Company Industry JurisdictionThis LICENSE AGREEMENT (this “Agreement”) is entered into effective as of February 23, 2014 (the “Effective Date”) between GENSIGHT BIOLOGICS, S.A., a French corporation with offices at 89, rue du Faubourg St Antoine 75011 Paris (“GenSight”), and AVALANCHE BIOTECHNOLOGIES, INC., a Delaware corporation with offices at 665 Third Street, Suite 280, San Francisco, CA 94107 (“Avalanche”).
LICENSE AGREEMENTLicense Agreement • June 18th, 2015 • Gensight Biologics • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 18th, 2015 Company Industry JurisdictionThis LICENSE AGREEMENT (this “Agreement”) is entered into effective as of February 23, 2014 (the “Effective Date”) between GENSIGHT BIOLOGICS, S.A., a French corporation with offices at 89, rue du Faubourg St Antoine 75011 Paris (“GenSight”), and AVALANCHE BIOTECHNOLOGIES, INC., a Delaware corporation with offices at 665 Third Street, Suite 280, San Francisco, CA 94107 (“Avalanche”).